Venous thromboembolism and melanoma

Minerva Cardioangiologica

Volumn 49, Issue 5, 2001, Pages 327-333

  Valente, M ^a,c   Pozzi Mucelli, F ^b   Ponte, E ^b  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c NONE   (Italy)

Author keywords

Melanoma; Pulmonary embolism; Venous thrombosis, etiology

Indexed keywords

ARTICLE; CASE REPORT; HUMAN; MALE; MELANOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; THROMBOEMBOLISM; TUMOR EMBOLISM;

HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; SKIN NEOPLASMS; THROMBOEMBOLISM;

EID: 0035490152     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Trousseau A. Pblegmasia alba dolens. Lectures on clinical medicine, delivered at the Hotel-Dieu de Paris. London: New Sydenham Society, 1872:281-95.
2. Sproul EE. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938;34:566-85.
3. Agnelli G. Venous thromboembolism and cancer: a two-way clinical association. Thromb Haemost 1997;78: 117-20.
4. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Haemost 1992;18:353-72.
5. Green KB, Silverstien RL. Hypercoagulability in cancer. Hematol Oncol Clin North 1996;10:499-530.
6. Patterson WP, Ringenberg OS. The pathophysiology of thrombosis in cancer. Semin Oncol 1990,2:140-6.
7. Pineo GR, Brain MC, Gallus AS, Hirsh J, Hatton MWC, Regoecai E. Tumor, mucus production and hypercoagulability. Ann N Y Acad Sci 1974;230:262-70.
8. Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. J Clin Invest 1981;67: 1665-71.
9. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 1985;24:5558-67.
10. Francis JL. Haemostasis and cancer. Med Lab Sci 1989;46:331-46.
11. Miyauchi S, Moroyama T, Kyoizumi S, Asakawa J, Okamoto T, Takada K. Malignant tumor cell lines produce interleukin-1-like factor. In Vitro Cell Dev Biol 1988;24:753-8.
12. Dvorak HF. Abnormalities of hemostasis in malignant disease. In: Colman EW, Hirsh J, Marder VJ, Salzman EW, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott Co., 1993:1238-54.
13. Edwards RL, Rickles FR. Thrombosis and cancer: In: Hull R, Pineo GF, editors. Disorders of thrombosis. Philadelphia: WB Saunders Co., 1996:374-82.
14. Falanga A, Barbui T, Rickles FR, Levine MN. Guidelines for clotting studies in cancer patients. Thromb Haemost 1993;70:540-2.
15. Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ. Cancer and venous thromboembolism. Am Heart J 1996;132:850-5.
16. Naschitz JE, Yeshurun D, Lev LM. Thromboembolism in cancer: hanging trends. Cancer 1993;71:1384-90.
17. Doll DC, Yarbor JW. Vascular toxicity associated with antineoplastic agents: Semin Oncol 1992;19:580-96.
18. Clahsen PC, Van de Velde CJ. Thromboembolic complications after perioperative chemotherapy in woman with early breast cancer: A European organization for research and treatment of breast cancer. Cancer cooperative group study. J Clin Oncol 1994;12:1266-71.
19. Lipton A, Harver HA, Hamilton RW. Venous thromboembolism as a side effect of tamoxifen treatment. Cancer Treat Rep 1984;68:887-9.
20. Hendrick A, Subramanian VP. Tamoxifen and thromboembolism. JAMA 1980;243:514-5.
21. Doll DC, Ringenberg QS, Yarbro JW. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986;4:1405-10.
22. Valente M, Ponte E. Trombosi e neoplasie. Minerva Cardioangiol 2000;48:117-27.
23. Semb KA, Aamdal S, Bohmann T, Lucas C, Gerard B. Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma. Melanoma Res 1998;8:65-72.
24. Donati MB, Gambacorti-Passerini C, Casali B, Falanga A, Vannotti P, Fossati G et al. Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res 1986;46(12 Pt 1):6471-4.
25. Bani MR, Falanga A, Alessio MG, Radice E, Consonni R, Giavazzi R et al. Blood coagulation change in nude mice bearing human colon carcinomas. Int J Cancer 1992;50(1):75-9.
26. Gordon SG, Cross BA. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker. Cancer Res 1990;50:6229-34.
27. Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988;71(4):870-5.
28. Donati MB, Falanga A, Consonni R, Alessio MG, Bassan R, Buelli M et al. Cancer procoagulant in acute non lymphoblastic leukemia: relationship of enzyme detection to disease activity. Thromb Haemost 1990;64(1):11-6.
29. Weitz IC, Israel VK, Liebman HA. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden. Cancer 1997;79:2024-7.